Hurley Ariel's most recent trade in Blueprint Medicines Corp was a trade of 2,752 Common Stock done at an average price of $54.1 . Disclosure was reported to the exchange on May 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.13 per share. | 05 May 2025 | 2,752 | 19,696 (0%) | 0% | 54.1 | 148,966 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 2,752 | 2,751 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 103.57 per share. | 05 May 2025 | 1,400 | 17,044 (0%) | 0% | 103.6 | 144,998 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 05 May 2025 | 1,252 | 18,444 (0%) | 0% | 102.5 | 128,343 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 104.78 per share. | 05 May 2025 | 100 | 16,944 (0%) | 0% | 104.8 | 10,478 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 1,326 | 16,944 (0%) | 0% | 88.8 | 117,749 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 7,007 | 7,007 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 6,506 | 21,473 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 95.16 per share. | 01 Mar 2025 | 1,075 | 18,270 (0%) | 0% | 95.2 | 102,297 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 89.63 per share. | 01 Mar 2025 | 775 | 20,698 (0%) | 0% | 89.6 | 69,463 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 01 Mar 2025 | 631 | 19,829 (0%) | 0% | 92 | 58,052 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 93.42 per share. | 01 Mar 2025 | 484 | 19,345 (0%) | 0% | 93.4 | 45,215 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 90.92 per share. | 01 Mar 2025 | 238 | 20,460 (0%) | 0% | 90.9 | 21,639 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.05 per share. | 13 Jan 2025 | 2,250 | 17,217 (0%) | 0% | 36.1 | 81,113 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 13 Jan 2025 | 2,250 | 14,967 (0%) | 0% | 100 | 225,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2025 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 12 Dec 2024 | 1,600 | 16,786 (0%) | 0% | 15.0 | 24,016 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2024 | 1,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 92.88 per share. | 12 Dec 2024 | 1,200 | 15,586 (0%) | 0% | 92.9 | 111,456 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 93.99 per share. | 12 Dec 2024 | 619 | 14,967 (0%) | 0% | 94.0 | 58,180 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.05 per share. | 15 May 2024 | 4,500 | 19,413 (0%) | 0% | 36.1 | 162,225 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 107.22 per share. | 15 May 2024 | 3,582 | 17,187 (0%) | 0% | 107.2 | 384,062 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 106.56 per share. | 15 May 2024 | 2,274 | 14,913 (0%) | 0% | 106.6 | 242,317 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.15 per share. | 15 May 2024 | 1,356 | 20,769 (0%) | 0% | 43.1 | 58,511 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,356 | 9,494 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 1,843 | 5,503 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.13 per share. | 02 May 2024 | 1,834 | 16,747 (0%) | 0% | 54.1 | 99,274 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 103.88 per share. | 02 May 2024 | 1,834 | 14,913 (0%) | 0% | 103.9 | 190,516 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 1,462 | 17,862 (0%) | 0% | 90.7 | 132,589 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 19,324 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 714 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 22 Dec 2023 | 714 | 14,324 (0%) | 0% | 90 | 64,260 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 22 Dec 2023 | 714 | 15,038 (0%) | 0% | 8.8 | 6,283 | Common Stock |
| Blueprint Medicines Corp | Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 3,654 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 84.35 per share. | 15 Dec 2023 | 1,827 | 14,584 (0%) | 0% | 84.3 | 154,107 | Common Stock |
| Blueprint Medicines Corp | Hurley Ariel | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 15 Dec 2023 | 1,827 | 16,411 (0%) | 0% | 1.9 | 3,416 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 15 Dec 2023 | 1,827 | 16,411 (0%) | 0% | 1.9 | 3,416 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 84.35 per share. | 15 Dec 2023 | 1,827 | 14,584 (0%) | 0% | 84.3 | 154,107 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 84.35 per share. | 15 Dec 2023 | 260 | 14,324 (0%) | 0% | 84.4 | 21,931 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 87.28 per share. | 15 Mar 2023 | 2,949 | 14,913 (0%) | 0% | 87.3 | 257,389 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,600 | 1,600 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 15 Mar 2023 | 800 | 17,862 (0%) | 0% | 90 | 72,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 15 Mar 2023 | 800 | 18,662 (0%) | 0% | 15.0 | 12,008 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 87.28 per share. | 15 Mar 2023 | 800 | 17,862 (0%) | 0% | 87.3 | 69,824 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 15 Mar 2023 | 800 | 18,662 (0%) | 0% | 15.0 | 12,008 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 1,091 | 14,210 (0%) | 0% | 45.7 | 49,881 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 44.40 per share. | 06 Mar 2023 | 35 | 14,175 (0%) | 0% | 44.4 | 1,554 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,850 | 10,850 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 5,425 | 15,301 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 57.15 per share. | 10 Mar 2022 | 2,339 | 9,616 (0%) | 0% | 57.2 | 133,674 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 60.27 per share. | 03 Mar 2022 | 761 | 12,211 (0%) | 0% | 60.3 | 45,865 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 03 Mar 2022 | 256 | 11,955 (0%) | 0% | 56.2 | 14,385 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,875 | 12,972 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 114.28 per share. | 16 Nov 2021 | 1,950 | 10,097 (0%) | 0% | 114.3 | 222,846 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 700 | 3,654 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 16 Nov 2021 | 700 | 10,797 (0%) | 0% | 1.9 | 1,309 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 16 Nov 2021 | 650 | 11,447 (0%) | 0% | 8.8 | 5,720 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 650 | 714 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 600 | 3,200 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 16 Nov 2021 | 600 | 12,047 (0%) | 0% | 15.0 | 9,006 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 23 Sep 2021 | 600 | 10,097 (0%) | 0% | 110 | 66,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2021 | 600 | 3,800 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 23 Sep 2021 | 600 | 10,697 (0%) | 0% | 15.0 | 9,006 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 13 Sep 2021 | 600 | 10,097 (0%) | 0% | 100 | 60,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.01 per share. | 13 Sep 2021 | 600 | 10,697 (0%) | 0% | 15.0 | 9,006 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 600 | 4,400 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 91.93 per share. | 17 Aug 2021 | 1,350 | 10,097 (0%) | 0% | 91.9 | 124,106 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 17 Aug 2021 | 700 | 11,447 (0%) | 0% | 1.9 | 1,309 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 700 | 4,354 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 17 Aug 2021 | 650 | 10,747 (0%) | 0% | 8.8 | 5,720 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 650 | 1,364 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 91.67 per share. | 01 Jun 2021 | 237 | 10,097 (0%) | 0% | 91.7 | 21,726 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 17 May 2021 | 3,055 | 10,097 (0%) | 0% | 95 | 290,225 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 700 | 5,054 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 17 May 2021 | 700 | 13,152 (0%) | 0% | 1.9 | 1,309 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 650 | 2,014 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 17 May 2021 | 650 | 12,452 (0%) | 0% | 8.8 | 5,720 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 98.45 per share. | 03 Mar 2021 | 512 | 12,659 (0%) | 0% | 98.4 | 50,406 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 6,375 | 6,375 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,187 | 13,171 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 99.51 per share. | 01 Mar 2021 | 1,700 | 13,171 (0%) | 0% | 99.5 | 169,167 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 01 Mar 2021 | 1,400 | 14,571 (0%) | 0% | 1.9 | 2,618 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 1,400 | 5,754 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 01 Mar 2021 | 300 | 14,871 (0%) | 0% | 8.8 | 2,640 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 300 | 2,664 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 01 Dec 2020 | 900 | 9,984 (0%) | 0% | 110 | 99,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 01 Dec 2020 | 900 | 10,884 (0%) | 0% | 8.8 | 7,920 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 900 | 2,964 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 109.08 per share. | 01 Dec 2020 | 138 | 9,984 (0%) | 0% | 109.1 | 15,053 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 100.92 per share. | 16 Nov 2020 | 1,700 | 9,984 (0%) | 0% | 100.9 | 171,564 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 1,400 | 7,154 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 16 Nov 2020 | 1,400 | 11,684 (0%) | 0% | 1.9 | 2,618 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 16 Nov 2020 | 300 | 10,284 (0%) | 0% | 8.8 | 2,640 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 300 | 3,864 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2020 | 600 | 4,164 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 07 Oct 2020 | 600 | 10,584 (0%) | 0% | 8.8 | 5,280 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 07 Oct 2020 | 600 | 9,984 (0%) | 0% | 100 | 60,000 | Common Stock |
| Blueprint Medicines Corp | Ariel Hurley | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2020 | 1,400 | 8,554 | - | - | Stock Option (Right to Buy) |